Top 20 Global Chemical Companies by Revenue in 2025

Givaudan announced its 2025 financial results. Group sales for the year totaled €7.472 billion (approximately USD 8.763 billion), up slightly from €7.412 billion in the prior year. EBITDA for the year amounted to €1.751 billion, down from €1.765 billion year-on-year. Net profit stood at €1.071 billion, compared to €1.09 billion in the previous year. Syensqo reported its Q4 and full-year 2025 results excluding discontinued operations. Q4 net sales were €1.329 billion (approximately USD 1.56 billion), down 11.7% year-on-year from €1.505 billion. Q4 EBITDA was €236 million, down 19.8% from €294 million year-on-year. Net profit attributable to shareholders was €31 million, down 59.3% from €76 million year-on-year. Full-year net sales totaled €5.762 billion (approximately USD 6.758 billion), down 6.5% from €6.162 billion in 2024. Full-year EBITDA was €1.187 billion, down 14.3% from €1.385 billion. Net profit attributable to shareholders was €381 million, down 31% from €553 million. LANXESS announced its Q4 and full-year 2025 results. Q4 group sales were €1.268 billion (approximately USD 1.487 billion), down 14.5% year-on-year from €1.483 billion. Q4 EBITDA was €87 million, down 29.3% from €123 million year-on-year. Q4 net loss was €398 million, compared to a net loss of €64 million in the prior-year quarter. Full-year group sales totaled €5.673 billion (approximately USD 6.653 billion), down 10.9% from €6.366 billion in 2024. Full-year EBITDA was €492 million, down 8.6% from €538 million. Full-year net loss was €577 million, compared to a net loss of €177 million in 2024. Solvay announced its Q4 and full-year 2025 results. Q4 net sales were €995 million (approximately USD 1.167 billion), down 12.3% year-on-year from €1.134 billion. Q4 EBITDA was €169 million, down 33.9% from €256 million year-on-year. Net profit attributable to shareholders was €13 million, down 86.7% from €101 million year-on-year. Full-year net sales totaled €4.262 billion (approximately USD 5.0 billion), down 9% from €4.686 billion in 2024. Full-year EBITDA was €881 million, down 16.3% from €1.052 billion. Net profit attributable to shareholders was €297 million, down 31.2% from €432 million. Specialty chemicals company Clariant announced its Q4 and full-year 2025 results.

In-depth Analysis: Where Lie the New Opportunities in Chemical Industry M&A and Restructuring?

The level of M&A activity in the global chemical industry reflects, to some extent, broader economic and geopolitical trends. According to Deloitte’s '2024 Global Chemical Industry M&A Outlook', the number of global chemical M&A deals declined by 16% in 2023, falling 26% below the five-year pre-pandemic average (2015–2019). Global chemical M&A deal value also dropped nearly 40% year-on-year in 2023. Looking back at 2023, although U.S. and European central banks had paused interest rate hikes, rates remained near decade-high levels, resulting in persistently high financing costs for transactions. Coupled with an exceptionally challenging revenue and profitability environment, many chemical companies adopted a more cautious stance toward investment and M&A—exerting downward pressure on overall M&A activity. Data from investment bank Young & Partners shows that only 20 deals valued above USD 25 million occurred in H1 2024, compared to 75 deals for all of 2023 and 86 for all of 2022. Private equity firms remain key participants in chemical M&A. Although private equity deal volume hit a ten-year low in 2023 amid tight credit markets, deal value showed signs of recovery. A notable large transaction was Apollo’s March 2023 acquisition of Univar Solutions for USD 8.1 billion—one of the largest chemical M&A deals of 2023. The transaction included a minority equity investment from a wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA), illustrating increasingly flexible participation models among private equity firms as they seek alternative capital sources to close deals. According to Kearney’s 'Global Chemical Industry M&A Integration Report', private equity firms have accumulated substantial amounts of uninvested capital. By subsector, chemical companies in 2023 prioritized cost control and working capital optimization. Many firms lacking perceived cost competitiveness pursued plant rationalization. While M&A activity in specialty chemicals and materials declined in 2023, it outperformed other subsectors. Buyers remained willing to acquire companies they viewed as possessing long-term, sustainable growth potential in end markets—for example, DuPont’s May announcement of its USD 1.75 billion acquisition of Spectrum Plastics, a recognized leader in the specialty medical devices and components market. By target country, the United States ranked first globally in terms of chemical M&A deal volume, followed by China and the United Kingdom. The U.S. experienced its lowest deal volume in a decade in 2023, largely due to ongoing inventory destocking. However, given its significant raw material cost advantages, M&A activity is expected to rebound in 2024 as monetary policy adjustments take effect. In the UK, M&A remains dominated by bulk chemicals, with sustainability and ESG themes taking center stage. Broader M&A themes include portfolio repositioning through strategic divestitures—several major corporations are actively shedding assets deemed non-core and/or underperforming—as well as increased healthcare spending, which has boosted demand for pharmaceutical-related chemical products.

Ascent Industries Outlines Specialty Chemical Focus, Midwest Acquisition and Q1 2026 EBITDA Loss

May 18, 2026

Ascent Industries (ACNT) announced a strategic shift to become a pure-play specialty chemicals company following the $14 million acquisition of Midwest Graphic Sales & Sigma Coatings. The company also reported consolidated adjusted EBITDA losses of $963 thousand for Q1 2026.

Stock Titan

2026-04-01

Ascent Industries Co. Announces Board Appointments, Effective April 1, 2026

2026-04-01

Ascent Industries Appoints Two Proven Specialty Chemicals Leaders to Board of Directors

2026-04-02

Ascent Industries Expands Board and Adds Independent Directors

2026-04-27

Ascent Industries Schedules First Quarter 2026 Earnings Conference Call for May 6

2026-05-01

Ascent Industries (ACNT.US) to Release Earnings Report After Market Close on May 6